erlotinib hydrochloride has been researched along with pyrazole in 1 studies
Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (pyrazole) | Trials (pyrazole) | Recent Studies (post-2010) (pyrazole) |
---|---|---|---|---|---|
4,353 | 786 | 3,033 | 1,152 | 0 | 596 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, QS; Sun, S; Tang, JF; Wang, XL; Yang, YS; Zhang, F; Zhang, YB; Zhu, HL | 1 |
1 other study(ies) available for erlotinib hydrochloride and pyrazole
Article | Year |
---|---|
Design, modification and 3D QSAR studies of novel 2,3-dihydrobenzo[b][1,4]dioxin-containing 4,5-dihydro-1H-pyrazole derivatives as inhibitors of B-Raf kinase.
Topics: Binding Sites; Cell Line, Tumor; Cell Proliferation; Dioxanes; Dioxins; Drug Design; Erlotinib Hydrochloride; Humans; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins B-raf; Pyrazoles; Quantitative Structure-Activity Relationship; Quinazolines; Thermodynamics | 2012 |